Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Validates Results of Previous Clinical Trials

Stock Information for BiondVax Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.